Breaking News

Cook Medical Sells Vertebroplasty Product Family to IZI Medical Products

By Business Wire | May 10, 2017

Is used in the growing market for treating vertebral compression fractures through a minimally invasive procedure.

Cook Medical is pleased to announce the sale of its comprehensive family of vertebroplasty products to IZI Medical Products, LLC. This sale includes the Duro-Ject Osteo-Site, Osteo-Force, and Vertefix brands in addition to other needles, injectors and cements. Moving this product family from Cook Medical to IZI Medical Products is a positive decision for both companies and for the patients impacted by spinal fractures.
 
“In the US, there’s an estimated 700,000 vertebral fractures a year due to osteoporosis1,” said Pete Yonkman, president of Cook Medical and Cook Group. “We were not giving this product family the resources it needed to continue to advance, so we’re pleased to have found it a new home with IZI Medical. The sale of our vertebroplasty product family allows us to concentrate on our primary product lines while allowing IZI Medical to focus on helping to treat patients suffering from spinal fractures.”
 
The vertebroplasty product family is used in the growing market for treating vertebral compression fractures through a minimally invasive procedure. IZI has planned a significant investment in a dedicated sales force, international distributor network, select product enhancements and new product development.
 
This product family is manufactured in Cook Medical’s Bloomington, Ind., facility where many other products are built. This change will not impact that facility or its employees.
IZI Medical is the interventional products platform of Shore Capital Partners.

Reference
1Ensrud KE, Schousboe JT. Clinical practice. Vertebral fractures. N Engl J Med. 2011;364(17):1634–1642.
  • Loading Orthopedic Devices with Biologics and Pharmaceuticals

    Loading Orthopedic Devices with Biologics and Pharmaceuticals

    Dr. Kevin Nelson, Founder and CSO, TissueGen Inc.||May 19, 2017
    Fiber technology enables the delivery of the therapeutic components via a biodegradable platform that can be implanted.

  • Looking Beneath the Surface

    Looking Beneath the Surface

    Sam Brusco, Associate Editor||May 19, 2017
    Surface treatments seek to improve orthopedic device usability, longevity, and bone integration.

  • Going to Extremes

    Going to Extremes

    Michael Barbella, Managing Editor||May 19, 2017
    The innovation and market value found in extremity solutions is prompting a change of heart among major orthopedic firms.